Vitality Biopharma Appoints Regulatory Advisor for Cannabis-Derived Prodrugs Program

Vitality Biopharma Appoints Regulatory Advisor for Cannabis-Derived Prodrugs Program
Vitality Biopharma has appointed Tracy Rockney, co-founder and chief operating officer at OneSource Regulatory, to the position of senior regulatory advisor. She will be responsible for the regulatory development of the company’s cannabosides-based prodrug candidate VB100 for inflammatory bowel disease (IBD). Based in Los Angeles, Vitality Biopharma is focused on the development of new drugs that can use cannabinoids to treat serious neurological and inflammatory disorders. They use a new class of cannabinoid prodrugs, known as cannabosides. Upon ingestion, these pr
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *